<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Risk of developing a carboplatin infusion reaction over cumulative cycles of therapy for BRCA mutation carriers versus non-carriers</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Risk of developing a carboplatin infusion reaction over cumulative cycles of therapy for BRCA mutation carriers versus non-carriers</h1>
<div class="graphic"><div class="figure"><div class="ttl">Risk of developing a carboplatin infusion reaction over cumulative cycles of therapy for BRCA mutation carriers versus non-carriers</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">HSR: hypersensitivity reactions.</div><div class="graphic_reference">Reprinted by permission from Macmillan Publishers Ltd on behalf of Cancer Research UK: British Journal of Cancer. Moon DH, Lee JM, Noonan AM, et al. Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions. Br J Cancer 2013; 109:1072. Copyright © 2013. <a href="http://www.nature.com/bjc" target="_blank">www.nature.com/bjc</a>.</div><div id="graphicVersion">Graphic 90682 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
